The ACS estimates that 626,140 people in the U.S. will die from cancer in 2026, amounting to about 1,720 deaths per day. Lung ...

Once-daily oral ICP-332 results in large reduction in eczema scores and shows favorable safety in adults with moderate-to-severe atopic dermatitis.

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...

Savolitinib and osimertinib combination significantly improves PFS in EGFR-mutated NSCLC with MET amplification compared to ...

Professor Paul Colombo has studied music-based mentoring, memory, and the benefits of music training over the course of his ...

Kanazawa University, have captured real-time images showing how a key brain enzyme organizes itself to help memory formation.

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...

Lynk’s zemprocitinib commercial partner, Simcere, will now continue the JAK inhibitor’s development across China in RA.

Enliven Therapeutics jumped on strong ELVN-001 phase 1b CML data, but a rich valuation may cap upside. Click here to read an ...

Ocular Therapeutix (OCUL) stock surges on rumors that Sanofi (SNY) is readying an improved bid to take over the company. Read ...

A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the Sbarro Institute in Philadelphia, the National Cancer Institute – Pascale ...

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer. The study shows that a combination of ...